While roxadustat had minimal or no effect on intermediate (glycated albumin) and long-term (HbA1c) markers of glycemic control, changes in cholesterol values were observed in the Diabetes and No Diabetes subgroups. The gene discussed is ALB; the disease is diabetes mellitus.